Loading…
Anti-Toxoplasma gondii Antibodies in Patients With Schizophrenia-Preliminary Findings in a Turkish Sample
Schizophrenia is a serious neuropsychiatric disease of uncertain etiology. We investigated the seropositivity rate for anti-Toxoplasma IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA) in patients with schizophrenia to ascertain a possible relationship between Toxoplasma gondii and...
Saved in:
Published in: | Schizophrenia bulletin 2007-05, Vol.33 (3), p.789-791 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c475t-f630daf72101517fcb8aed2786d11ea06f0cf7568dc7303c542bb1fb0fedcbcd3 |
---|---|
cites | |
container_end_page | 791 |
container_issue | 3 |
container_start_page | 789 |
container_title | Schizophrenia bulletin |
container_volume | 33 |
creator | Cetinkaya, Zafer Yazar, Suleyman Gecici, Omer Namli, Mustafa N. |
description | Schizophrenia is a serious neuropsychiatric disease of uncertain etiology. We investigated the seropositivity rate for anti-Toxoplasma IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA) in patients with schizophrenia to ascertain a possible relationship between Toxoplasma gondii and schizophrenia. We selected 100 patients with schizophrenia, 50 with depressive disorder, and 50 healthy volunteers to investigate the seropositivity rate of anti-Toxoplasma antibodies by ELISA. The seropositivity rate for anti-Toxoplasma IgG antibodies among schizophrenia patients (66%) was significantly higher than among patients with depressive disorder or healthy volunteers (P |
doi_str_mv | 10.1093/schbul/sbm021 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2526136</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/schbul/sbm021</oup_id><sourcerecordid>70526996</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-f630daf72101517fcb8aed2786d11ea06f0cf7568dc7303c542bb1fb0fedcbcd3</originalsourceid><addsrcrecordid>eNqF0VFr1TAUB_AgDnedPvoqRVB8qUvSJmlfhDGcDgYOvOJjSNPk9sw0qUkr6qc311626YtPgZPfOfmHg9Azgt8Q3FanSQ_d4k5TN2JKHqANETUricDkIdpg1vBScFIfo8cp3WBM6pbTR-g4I1xXTbNBcOZnKLfhR5icSqMqdsH3AMW-3IUeTCrAF9dqBuPnVHyBeSg-6QF-hWmIxoMqr6NxMIJX8WdxAbnZ7_70qGK7xK-Qslfj5MwTdGSVS-bp4TxBny_ebc8_lFcf31-en12VuhZsLi2vcK-soAQTRoTVXaNMT0XDe0KMwtxibQXjTa9FhSvNatp1xHbYml53uq9O0Nt17rR0Y67l3FE5OUUYc0QZFMi_bzwMche-S8ooJxXPA14dBsTwbTFpliMkbZxT3oQlSYEzbNs9fPEPvAlL9PlzktKKMUJ5k1G5Ih1DStHY2yQEy_0G5bpBuW4w--f349_pw8oyeHkAKmnlbFReQ7pzmeC6pdm9Xl1Ypv-8-RvXCLbn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223551268</pqid></control><display><type>article</type><title>Anti-Toxoplasma gondii Antibodies in Patients With Schizophrenia-Preliminary Findings in a Turkish Sample</title><source>PMC (PubMed Central)</source><source>Oxford Journals Online</source><creator>Cetinkaya, Zafer ; Yazar, Suleyman ; Gecici, Omer ; Namli, Mustafa N.</creator><creatorcontrib>Cetinkaya, Zafer ; Yazar, Suleyman ; Gecici, Omer ; Namli, Mustafa N.</creatorcontrib><description>Schizophrenia is a serious neuropsychiatric disease of uncertain etiology. We investigated the seropositivity rate for anti-Toxoplasma IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA) in patients with schizophrenia to ascertain a possible relationship between Toxoplasma gondii and schizophrenia. We selected 100 patients with schizophrenia, 50 with depressive disorder, and 50 healthy volunteers to investigate the seropositivity rate of anti-Toxoplasma antibodies by ELISA. The seropositivity rate for anti-Toxoplasma IgG antibodies among schizophrenia patients (66%) was significantly higher than among patients with depressive disorder or healthy volunteers (P < .01). Thus, there might be a causal relationship between toxoplasmosis and the etiology of schizophrenia.</description><identifier>ISSN: 0586-7614</identifier><identifier>EISSN: 1745-1701</identifier><identifier>DOI: 10.1093/schbul/sbm021</identifier><identifier>PMID: 17404388</identifier><identifier>CODEN: SCZBB3</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Adult and adolescent clinical studies ; Animals ; Antibodies, Protozoan - blood ; Biological and medical sciences ; Comorbidity ; Cross-Sectional Studies ; Depressive Disorder - diagnosis ; Depressive Disorder - epidemiology ; Depressive Disorder - immunology ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunoglobulin G - blood ; Immunoglobulin M - blood ; Male ; Medical sciences ; Middle Aged ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Regular ; Schizophrenia ; Schizophrenia - diagnosis ; Schizophrenia - epidemiology ; Schizophrenia - immunology ; Statistics as Topic ; Toxoplasma - immunology ; Toxoplasmosis, Cerebral - diagnosis ; Toxoplasmosis, Cerebral - epidemiology ; Toxoplasmosis, Cerebral - immunology ; Turkey</subject><ispartof>Schizophrenia bulletin, 2007-05, Vol.33 (3), p.789-791</ispartof><rights>The Author 2007. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org. 2007</rights><rights>2007 INIST-CNRS</rights><rights>The Author 2007. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-f630daf72101517fcb8aed2786d11ea06f0cf7568dc7303c542bb1fb0fedcbcd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526136/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526136/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18830492$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17404388$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cetinkaya, Zafer</creatorcontrib><creatorcontrib>Yazar, Suleyman</creatorcontrib><creatorcontrib>Gecici, Omer</creatorcontrib><creatorcontrib>Namli, Mustafa N.</creatorcontrib><title>Anti-Toxoplasma gondii Antibodies in Patients With Schizophrenia-Preliminary Findings in a Turkish Sample</title><title>Schizophrenia bulletin</title><addtitle>Schizophr Bull</addtitle><description>Schizophrenia is a serious neuropsychiatric disease of uncertain etiology. We investigated the seropositivity rate for anti-Toxoplasma IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA) in patients with schizophrenia to ascertain a possible relationship between Toxoplasma gondii and schizophrenia. We selected 100 patients with schizophrenia, 50 with depressive disorder, and 50 healthy volunteers to investigate the seropositivity rate of anti-Toxoplasma antibodies by ELISA. The seropositivity rate for anti-Toxoplasma IgG antibodies among schizophrenia patients (66%) was significantly higher than among patients with depressive disorder or healthy volunteers (P < .01). Thus, there might be a causal relationship between toxoplasmosis and the etiology of schizophrenia.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Animals</subject><subject>Antibodies, Protozoan - blood</subject><subject>Biological and medical sciences</subject><subject>Comorbidity</subject><subject>Cross-Sectional Studies</subject><subject>Depressive Disorder - diagnosis</subject><subject>Depressive Disorder - epidemiology</subject><subject>Depressive Disorder - immunology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin M - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Regular</subject><subject>Schizophrenia</subject><subject>Schizophrenia - diagnosis</subject><subject>Schizophrenia - epidemiology</subject><subject>Schizophrenia - immunology</subject><subject>Statistics as Topic</subject><subject>Toxoplasma - immunology</subject><subject>Toxoplasmosis, Cerebral - diagnosis</subject><subject>Toxoplasmosis, Cerebral - epidemiology</subject><subject>Toxoplasmosis, Cerebral - immunology</subject><subject>Turkey</subject><issn>0586-7614</issn><issn>1745-1701</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqF0VFr1TAUB_AgDnedPvoqRVB8qUvSJmlfhDGcDgYOvOJjSNPk9sw0qUkr6qc311626YtPgZPfOfmHg9Azgt8Q3FanSQ_d4k5TN2JKHqANETUricDkIdpg1vBScFIfo8cp3WBM6pbTR-g4I1xXTbNBcOZnKLfhR5icSqMqdsH3AMW-3IUeTCrAF9dqBuPnVHyBeSg-6QF-hWmIxoMqr6NxMIJX8WdxAbnZ7_70qGK7xK-Qslfj5MwTdGSVS-bp4TxBny_ebc8_lFcf31-en12VuhZsLi2vcK-soAQTRoTVXaNMT0XDe0KMwtxibQXjTa9FhSvNatp1xHbYml53uq9O0Nt17rR0Y67l3FE5OUUYc0QZFMi_bzwMche-S8ooJxXPA14dBsTwbTFpliMkbZxT3oQlSYEzbNs9fPEPvAlL9PlzktKKMUJ5k1G5Ih1DStHY2yQEy_0G5bpBuW4w--f349_pw8oyeHkAKmnlbFReQ7pzmeC6pdm9Xl1Ypv-8-RvXCLbn</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Cetinkaya, Zafer</creator><creator>Yazar, Suleyman</creator><creator>Gecici, Omer</creator><creator>Namli, Mustafa N.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20070501</creationdate><title>Anti-Toxoplasma gondii Antibodies in Patients With Schizophrenia-Preliminary Findings in a Turkish Sample</title><author>Cetinkaya, Zafer ; Yazar, Suleyman ; Gecici, Omer ; Namli, Mustafa N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-f630daf72101517fcb8aed2786d11ea06f0cf7568dc7303c542bb1fb0fedcbcd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Animals</topic><topic>Antibodies, Protozoan - blood</topic><topic>Biological and medical sciences</topic><topic>Comorbidity</topic><topic>Cross-Sectional Studies</topic><topic>Depressive Disorder - diagnosis</topic><topic>Depressive Disorder - epidemiology</topic><topic>Depressive Disorder - immunology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin M - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Regular</topic><topic>Schizophrenia</topic><topic>Schizophrenia - diagnosis</topic><topic>Schizophrenia - epidemiology</topic><topic>Schizophrenia - immunology</topic><topic>Statistics as Topic</topic><topic>Toxoplasma - immunology</topic><topic>Toxoplasmosis, Cerebral - diagnosis</topic><topic>Toxoplasmosis, Cerebral - epidemiology</topic><topic>Toxoplasmosis, Cerebral - immunology</topic><topic>Turkey</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cetinkaya, Zafer</creatorcontrib><creatorcontrib>Yazar, Suleyman</creatorcontrib><creatorcontrib>Gecici, Omer</creatorcontrib><creatorcontrib>Namli, Mustafa N.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Schizophrenia bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cetinkaya, Zafer</au><au>Yazar, Suleyman</au><au>Gecici, Omer</au><au>Namli, Mustafa N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Toxoplasma gondii Antibodies in Patients With Schizophrenia-Preliminary Findings in a Turkish Sample</atitle><jtitle>Schizophrenia bulletin</jtitle><addtitle>Schizophr Bull</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>33</volume><issue>3</issue><spage>789</spage><epage>791</epage><pages>789-791</pages><issn>0586-7614</issn><eissn>1745-1701</eissn><coden>SCZBB3</coden><abstract>Schizophrenia is a serious neuropsychiatric disease of uncertain etiology. We investigated the seropositivity rate for anti-Toxoplasma IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA) in patients with schizophrenia to ascertain a possible relationship between Toxoplasma gondii and schizophrenia. We selected 100 patients with schizophrenia, 50 with depressive disorder, and 50 healthy volunteers to investigate the seropositivity rate of anti-Toxoplasma antibodies by ELISA. The seropositivity rate for anti-Toxoplasma IgG antibodies among schizophrenia patients (66%) was significantly higher than among patients with depressive disorder or healthy volunteers (P < .01). Thus, there might be a causal relationship between toxoplasmosis and the etiology of schizophrenia.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>17404388</pmid><doi>10.1093/schbul/sbm021</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0586-7614 |
ispartof | Schizophrenia bulletin, 2007-05, Vol.33 (3), p.789-791 |
issn | 0586-7614 1745-1701 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2526136 |
source | PMC (PubMed Central); Oxford Journals Online |
subjects | Adult Adult and adolescent clinical studies Animals Antibodies, Protozoan - blood Biological and medical sciences Comorbidity Cross-Sectional Studies Depressive Disorder - diagnosis Depressive Disorder - epidemiology Depressive Disorder - immunology Enzyme-Linked Immunosorbent Assay Female Humans Immunoglobulin G - blood Immunoglobulin M - blood Male Medical sciences Middle Aged Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Regular Schizophrenia Schizophrenia - diagnosis Schizophrenia - epidemiology Schizophrenia - immunology Statistics as Topic Toxoplasma - immunology Toxoplasmosis, Cerebral - diagnosis Toxoplasmosis, Cerebral - epidemiology Toxoplasmosis, Cerebral - immunology Turkey |
title | Anti-Toxoplasma gondii Antibodies in Patients With Schizophrenia-Preliminary Findings in a Turkish Sample |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A44%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Toxoplasma%20gondii%20Antibodies%20in%20Patients%20With%20Schizophrenia-Preliminary%20Findings%20in%20a%20Turkish%20Sample&rft.jtitle=Schizophrenia%20bulletin&rft.au=Cetinkaya,%20Zafer&rft.date=2007-05-01&rft.volume=33&rft.issue=3&rft.spage=789&rft.epage=791&rft.pages=789-791&rft.issn=0586-7614&rft.eissn=1745-1701&rft.coden=SCZBB3&rft_id=info:doi/10.1093/schbul/sbm021&rft_dat=%3Cproquest_pubme%3E70526996%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-f630daf72101517fcb8aed2786d11ea06f0cf7568dc7303c542bb1fb0fedcbcd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=223551268&rft_id=info:pmid/17404388&rft_oup_id=10.1093/schbul/sbm021&rfr_iscdi=true |